Onyx Biotec Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	15.18	14.67	0.07	0.14
Cash & Short-Term Investments	15.18	14.67	0.07	0.14
Cash Growth	-	19721.62%	-45.59%	-
Accounts Receivable	182.54	153.73	50.76	84.17
Other Receivables	-	-	0.86	0.38
Receivables	183.99	153.73	51.61	84.55
Inventory	118.54	91.03	63.29	30.53
Prepaid Expenses	-	0.84	0.67	0.53
Other Current Assets	29.66	35.32	30	28.58
Total Current Assets	347.37	295.58	145.64	144.32
Property, Plant & Equipment	419.12	434.77	425.04	212.58
Long-Term Investments	-	6.4	11.98	8.01
Other Long-Term Assets	11.41	4.6	4.57	3.48
Total Assets	777.9	741.36	587.24	368.38
Accounts Payable	138.22	137.86	69.23	43.16
Accrued Expenses	-	9.7	14.85	17.7
Short-Term Debt	123.18	29.24	72.99	12.43
Current Portion of Long-Term Debt	-	42.65	39.14	23.71
Current Income Taxes Payable	-	2.73	-	-
Current Unearned Revenue	-	0.03	-	-
Other Current Liabilities	25.6	3.8	5.87	3.32
Total Current Liabilities	287	226.02	202.08	100.32
Long-Term Debt	178.47	235.91	180.16	86.3
Long-Term Deferred Tax Liabilities	29.69	25.74	18.63	14.2
Total Liabilities	495.17	492.57	405.22	204.63
Common Stock	133.22	133.22	59.02	59.02
Additional Paid-In Capital	-	21.27	2.19	2.19
Retained Earnings	-	94.3	120.81	102.55
Shareholders' Equity	282.74	248.79	182.02	163.76
Total Liabilities & Equity	777.9	741.36	587.24	368.38
Total Debt	301.65	307.8	292.28	122.44
Net Cash (Debt)	-286.46	-293.14	-292.21	-122.3
Net Cash Per Share	-22.53	-24.56	-24.76	-10.36
Filing Date Shares Outstanding	13.33	13.32	11.8	11.8
Total Common Shares Outstanding	13.33	13.32	11.8	11.8
Working Capital	60.36	69.56	-56.43	44
Book Value Per Share	21.21	18.67	15.42	13.87
Tangible Book Value	282.74	248.79	182.02	163.76
Tangible Book Value Per Share	21.21	18.67	15.42	13.87
Land	-	18.87	18.87	7.85
Buildings	-	125.51	121.33	64.08
Machinery	-	456.87	428.83	231.25
Construction In Progress	-	-	-	40.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.